Document is current
Any future updates will be listed below
-
Authors
Starling, Amaal J.
Kymes, Steven
Asher, Divya
Soni-Brahmbhatt, Seema
Karnik-Henry, Meghana
-
Funding
Funding for this research was provided by:
Lundbeck, LLC
- License Information
-
More Information
Article History
Received: 12 August 2022
Accepted: 11 April 2023
First Online: 20 April 2023
Declarations
:
: The study was conducted in accordance with Good Clinical Practice guidelines, the principles of the Declaration of Helsinki, and all applicable regulatory requirements. Institutional review board approval was obtained from Advarra, Inc, for this protocol on 22 November 2021 (Advarra protocol number: 00059159). Patients provided written informed consent prior to initiation of any study procedures.
: Not applicable.
: AS has received consulting fees from Allergan/AbbVie, Amgen, Axsome Therapeutics, Eli Lilly, Everyday Health, Impel, Lundbeck, Med-IQ, Medscape, Neurolief, Novartis, Satsuma, Teva, and Theranica.DA and SS-B are employees of Lundbeck LLC.SK and MK-H were employees of Lundbeck LLC when this study was performed.
